Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins
- PMID: 17698570
- PMCID: PMC2168310
- DOI: 10.1128/IAI.00773-07
Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins
Abstract
Immunity to pneumococcal colonization in mice by exposure to live or killed pneumococci has been shown to be antibody independent but dependent on CD4+ T cells. Here we show that intranasal immunization with pneumococcal proteins (pneumococcal surface protein C, adhesin A, and a pneumolysoid) can elicit a similar mechanism of protection. Colonization could be significantly reduced in mice congenitally deficient in immunoglobulins after intranasal immunization with this mixture of proteins; conversely, the depletion of CD4+ T cells in immunized wild-type mice at the time of challenge eliminated the protection afforded by immunization. Overall, our results show that intranasal immunization with a mixture of pneumococcal proteins protects against colonization in an antibody-independent, CD4+ T-cell-dependent manner.
Figures


Similar articles
-
CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization.Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4848-53. doi: 10.1073/pnas.0501254102. Epub 2005 Mar 21. Proc Natl Acad Sci U S A. 2005. PMID: 15781870 Free PMC article.
-
Protection Elicited by Nasal Immunization with Recombinant Pneumococcal Surface Protein A (rPspA) Adjuvanted with Whole-Cell Pertussis Vaccine (wP) against Co-Colonization of Mice with Streptococcus pneumoniae.PLoS One. 2017 Jan 19;12(1):e0170157. doi: 10.1371/journal.pone.0170157. eCollection 2017. PLoS One. 2017. PMID: 28103277 Free PMC article.
-
Intranasal Immunization with the Commensal Streptococcus mitis Confers Protective Immunity against Pneumococcal Lung Infection.Appl Environ Microbiol. 2019 Mar 6;85(6):e02235-18. doi: 10.1128/AEM.02235-18. Print 2019 Mar 15. Appl Environ Microbiol. 2019. PMID: 30683742 Free PMC article.
-
Protective immunity of pneumococcal glycoconjugates.Crit Rev Microbiol. 2003;29(4):333-49. doi: 10.1080/713608018. Crit Rev Microbiol. 2003. PMID: 14636043 Review.
-
Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development.J Mol Med (Berl). 2010 Feb;88(2):135-42. doi: 10.1007/s00109-009-0579-4. Epub 2010 Jan 5. J Mol Med (Berl). 2010. PMID: 20049411 Review.
Cited by
-
Tissue-expressed B7x affects the immune response to and outcome of lethal pulmonary infection.J Immunol. 2012 Sep 15;189(6):3054-63. doi: 10.4049/jimmunol.1200701. Epub 2012 Aug 1. J Immunol. 2012. PMID: 22855708 Free PMC article.
-
Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation.Front Immunol. 2018 Oct 18;9:2405. doi: 10.3389/fimmu.2018.02405. eCollection 2018. Front Immunol. 2018. PMID: 30405609 Free PMC article.
-
Preclinical evaluation of a chemically detoxified pneumolysin as pneumococcal vaccine antigen.Hum Vaccin Immunother. 2017 Jan 2;13(1):220-228. doi: 10.1080/21645515.2016.1234553. Epub 2016 Oct 21. Hum Vaccin Immunother. 2017. PMID: 27768518 Free PMC article.
-
Identification of protective pneumococcal T(H)17 antigens from the soluble fraction of a killed whole cell vaccine.PLoS One. 2012;7(8):e43445. doi: 10.1371/journal.pone.0043445. Epub 2012 Aug 14. PLoS One. 2012. PMID: 22905267 Free PMC article.
-
Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae.Clin Vaccine Immunol. 2011 Jan;18(1):75-81. doi: 10.1128/CVI.00263-10. Epub 2010 Nov 3. Clin Vaccine Immunol. 2011. PMID: 21047997 Free PMC article.
References
-
- Alexander, J. E., R. A. Lock, C. C. Peeters, J. T. Poolman, P. W. Andrew, T. J. Mitchell, D. Hansman, and J. C. Paton. 1994. Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae. Infect. Immun. 62:5683-5688. - PMC - PubMed
-
- Arulanandam, B. P., J. M. Lynch, D. E. Briles, S. Hollingshead, and D. W. Metzger. 2001. Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection. Infect. Immun. 69:6718-6724. - PMC - PubMed
-
- Austrian, R. 1986. Some aspects of the pneumococcal carrier state. J. Antimicrob. Chemother. 18(Suppl. A):35-45. - PubMed
-
- Balachandran, P., A. Brooks-Walter, A. Virolainen-Julkunen, S. K. Hollingshead, and D. E. Briles. 2002. Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae. Infect. Immun. 70:2526-2534. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials